NJCC_01 v7 bwerk.indd
نویسندگان
چکیده
Fluid administration in critically ill patients is an important everyday therapeutic measure to improve organ perfusion. However, during the past decade, excessive fluid administration has been related to increased morbidity and mortality. This has led to the hypotheses that fluid administration without increasing cardiac output is inappropriate and is of no benefit to the patient. Over the past 10 years, many parameters for the prediction of fluid responsiveness have been suggested and validated. Implementation of these parameters in clinical practice may reduce the amount of inappropriate fluid. In this paper we discuss these methods for predicting fluid responsiveness and present a clinical strategy for fluid resuscitation. We make separate recommendations for patients on controlled mechanical ventilation, on mechanical ventilation with spontaneous activity and those breathing spontaneously.
منابع مشابه
Serial blood-based analysis of AR-V7 in men with advanced prostate cancer.
BACKGROUND We previously showed that pretreatment detection of androgen receptor splice variant-7 (AR-V7) in circulating tumor cells (CTCs) from men with castration-resistant prostate cancer is associated with resistance to abiraterone and enzalutamide, but not to taxane chemotherapies. Here, we conducted serial measurements of AR-V7 and evaluated patterns of longitudinal AR-V7 dynamics over th...
متن کاملDroplet Digital PCR Based Androgen Receptor Variant 7 (AR-V7) Detection from Prostate Cancer Patient Blood Biopsies
Androgen receptor splice variant V7 (AR-V7) was recently identified as a valuable predictive biomarker in metastatic castrate-resistant prostate cancer. Here, we report a new, sensitive and accurate screen for AR-V7 mRNA expression directly from circulating tumor cells (CTCs): We combined EpCAM-based immunomagnetic CTC isolation using the IsoFlux microfluidic platform with droplet digital polym...
متن کاملNiclosamide enhances abiraterone treatment via inhibition of androgen receptor variants in castration resistant prostate cancer
Considerable evidence from both clinical and experimental studies suggests that androgen receptor variants, particularly androgen receptor variant 7 (AR-V7), are critical in the induction of resistance to enzalutamide and abiraterone. In this study, we investigated the role of AR-V7 in the cross-resistance of enzalutamide and abiraterone and examined if inhibition of AR-V7 can improve abiratero...
متن کاملTargeted suppression of AR-V7 using PIP5K1α inhibitor overcomes enzalutamide resistance in prostate cancer cells
One mechanism of resistance of prostate cancer (PCa) to enzalutamide (MDV3100) treatment is the increased expression of AR variants lacking the ligand binding-domain, the best characterized of which is AR-V7. We have previously reported that Phosphatidylinositol-4-phosphate 5-kinase alpha (PIP5Kα), is a lipid kinase that links to CDK1 and AR pathways. The discovery of PIP5Kα inhibitor highlight...
متن کاملAnalytical Validation and Clinical Qualification of a New Immunohistochemical Assay for Androgen Receptor Splice Variant-7 Protein Expression in Metastatic Castration-resistant Prostate Cancer
BACKGROUND The androgen receptor splice variant-7 (AR-V7) has been implicated in the development of castration-resistant prostate cancer (CRPC) and resistance to abiraterone and enzalutamide. OBJECTIVE To develop a validated assay for detection of AR-V7 protein in tumour tissue and determine its expression and clinical significance as patients progress from hormone-sensitive prostate cancer (...
متن کامل